Profile data is unavailable for this security.
About the company
Beijing Tong Ren Tang Chinese Medicine Company Limited is a company mainly engaged in the manufacturing and sale of Chinese medicine. Along with subsidiaries, it operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. It is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.
- Revenue in HKD (TTM)1.52bn
- Net income in HKD540.39m
- Incorporated2004
- Employees798.00
- LocationBeijing Tong Ren Tang Chinese Medicine Co LtdRoom 1405-1409, Office Tower, Hong KongHKG
- Phone+852 36575819
- Fax+852 28817606
- Websitehttps://cm.tongrentang.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 872.67m | 110.20m | 6.19bn | 948.00 | 19.61 | 0.8553 | -- | 7.09 | 0.1071 | 0.1071 | 0.8287 | 2.46 | 0.2852 | 1.44 | 1.62 | 920,541.00 | 3.59 | 7.03 | 4.35 | 9.05 | 91.40 | 92.17 | 12.59 | 17.26 | 3.94 | 568.37 | 0.0062 | 39.16 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | 0.00 |
| Qyuns Therapeutics Co Ltd | 0.00 | -547.55m | 6.24bn | 331.00 | -- | 19.63 | -- | -- | -2.47 | -2.47 | 0.00 | 1.43 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.64 | -69.52 | 0.5349 | -- | -- | -- | -70.28 | -- | -- | -- |
| New Horizon Health Ltd | 1.47bn | 119.30m | 6.47bn | 1.04k | 59.24 | 2.01 | 41.66 | 4.41 | 0.2387 | 0.2387 | 3.22 | 7.04 | 0.4536 | 2.16 | 2.08 | 1,672,843.00 | 3.67 | -- | 3.99 | -- | 88.74 | -- | 8.10 | -- | 10.50 | -- | 0.1305 | -- | 259.54 | -- | 97.40 | -- | -- | -- |
| Tong Ren Tang Technologies Co Ltd | 7.30bn | 636.46m | 7.04bn | 4.10k | 11.07 | 0.9482 | 5.15 | 0.9644 | 0.4969 | 0.4969 | 5.70 | 5.80 | 0.5212 | 0.9835 | 5.68 | 1,781,144.00 | 7.64 | 7.68 | 12.10 | 12.32 | 42.04 | 43.50 | 14.65 | 16.11 | 2.37 | -- | 0.1443 | 39.94 | 13.04 | 6.01 | 1.25 | -2.73 | -22.26 | 0.0178 |
| China Shineway Pharmaceutical Group Ltd | 4.87bn | 1.05bn | 7.41bn | 3.44k | 6.47 | 0.9768 | 6.05 | 1.52 | 1.38 | 1.38 | 6.45 | 9.17 | 0.5073 | 1.44 | 6.31 | 1,417,524.00 | 10.89 | 8.03 | 14.15 | 9.77 | 75.15 | 74.55 | 21.47 | 17.87 | 2.98 | -- | 0.0411 | 36.29 | 14.32 | 11.94 | 34.14 | 13.89 | 0.6396 | 12.88 |
| Lepu Biopharma Co Ltd | 243.02m | -23.83m | 7.43bn | 429.00 | -- | 7.69 | 95.58 | 30.59 | -0.0144 | -0.0144 | 0.1465 | 0.5829 | 0.0917 | 1.06 | 1.62 | 566,476.80 | -1.23 | -- | -1.91 | -- | 87.45 | -- | -13.45 | -- | 0.7201 | 0.1388 | 0.4549 | -- | 1,347.16 | -- | 96.79 | -- | -- | -- |
| Everest Medicines Ltd | 135.80m | -910.67m | 7.48bn | 432.00 | -- | 1.37 | -- | 55.11 | -2.91 | -2.91 | 0.4338 | 16.78 | 0.0203 | 2.25 | 4.57 | 314,362.20 | -13.63 | -30.52 | -15.06 | -33.14 | 72.67 | -- | -670.57 | -5,745.25 | 8.29 | -- | 0.0979 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
| Beijing Tong Ren Tang Chinese Medicine | 1.52bn | 540.39m | 8.09bn | 798.00 | 14.98 | 2.09 | 12.03 | 5.31 | 0.6456 | 0.6456 | 1.82 | 4.62 | 0.3522 | 0.6449 | 2.31 | 1,910,959.00 | 13.64 | 16.71 | 15.50 | 18.75 | 68.67 | 69.88 | 38.73 | 40.72 | 8.59 | -- | 0.0317 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
| Yichang Hec Changjiang Pharmactcl Co Ltd | 6.79bn | 2.15bn | 8.82bn | 4.62k | 4.10 | 1.03 | 3.64 | 1.30 | 2.44 | 2.44 | 7.71 | 9.72 | 0.5111 | 3.62 | 4.09 | 1,469,912.00 | 15.07 | 8.03 | 24.46 | 11.81 | 79.21 | 79.97 | 29.48 | 20.80 | 1.30 | 11.16 | 0.2475 | 15.81 | 68.08 | 20.18 | 2,501.24 | 16.15 | -11.50 | -- |
| AIM Vaccine Co Ltd | 1.28bn | -1.40bn | 8.94bn | 1.62k | -- | 2.28 | -- | 6.98 | -1.16 | -1.16 | 1.06 | 3.24 | -- | -- | -- | 788,522.10 | -- | -- | -- | -- | 75.88 | -- | -164.24 | -- | 0.7583 | -14.04 | 0.3158 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
| InnoCare Pharma Ltd | 796.43m | -680.75m | 9.00bn | 1.09k | -- | 1.05 | -- | 11.30 | -0.4036 | -0.4036 | 0.472 | 4.37 | 0.073 | 1.39 | 3.39 | 731,345.10 | -6.38 | -13.41 | -8.08 | -15.36 | 82.61 | 85.99 | -87.42 | -172.16 | 4.13 | -- | 0.1582 | -- | 18.09 | 240.36 | 28.80 | -- | 66.20 | -- |
| Cansino Biologics Inc | 372.24m | -1.60bn | 9.26bn | 1.49k | -- | 0.9577 | -- | 24.87 | -6.48 | -6.48 | 1.51 | 23.02 | 0.0332 | 2.37 | 0.4619 | 249,158.40 | -18.93 | -4.27 | -26.69 | -5.60 | -253.78 | -- | -569.97 | -27.72 | 1.86 | -- | 0.3381 | -- | -66.52 | 213.94 | -63.04 | -- | 30.60 | -- |
| Keymed Biosciences Inc | 381.85m | -387.53m | 9.55bn | 897.00 | -- | 2.97 | -- | 25.02 | -1.49 | -1.49 | 1.45 | 11.51 | 0.0906 | 0.7314 | 26.14 | 425,701.70 | -9.16 | -- | -10.05 | -- | 89.59 | -- | -101.04 | -- | 9.18 | -- | 0.123 | -- | 253.87 | -- | -16.63 | -- | -- | -- |
| Luye Pharma Group Ltd | 6.62bn | 574.36m | 10.01bn | 5.27k | 17.34 | 0.7404 | 7.48 | 1.51 | 0.1534 | 0.1534 | 1.78 | 3.59 | 0.247 | 2.42 | 3.60 | 1,257,053.00 | 2.17 | 2.80 | 3.56 | 4.45 | 68.44 | 70.53 | 8.78 | 10.39 | 1.21 | 3.10 | 0.3931 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
| Shanghai Henlius Biotech Inc | 5.82bn | 588.82m | 10.24bn | 3.64k | 17.44 | 4.33 | 10.49 | 1.76 | 1.08 | 1.08 | 10.66 | 4.35 | 0.5731 | 1.95 | 9.10 | 1,599,627.00 | 5.80 | -8.59 | 12.47 | -14.14 | 72.64 | 71.77 | 10.12 | -27.37 | 0.3786 | 6.48 | 0.6512 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
Data as of May 27 2024. Currency figures normalised to Beijing Tong Ren Tang Chinese Medicine Co Ltd's reporting currency: Hong Kong Dollar HKD
7.66%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Value Partners Ltd.as of 30 Jun 2023 | 26.04m | 3.11% |
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 10.73m | 1.28% |
| The Vanguard Group, Inc.as of 09 May 2024 | 8.34m | 1.00% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 6.23m | 0.74% |
| BlackRock Fund Advisorsas of 09 May 2024 | 3.97m | 0.47% |
| Dimensional Fund Advisors LPas of 09 May 2024 | 3.32m | 0.40% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2022 | 1.96m | 0.23% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 1.65m | 0.20% |
| RAM Active Investments SAas of 30 Jun 2023 | 937.00k | 0.11% |
| Manulife Investment Management (Hong Kong) Ltd.as of 31 Oct 2023 | 901.00k | 0.11% |
More ▼
Data from 30 Jun 2023 - 22 May 2024Source: FactSet Research Systems Inc.
